Effect of silymarin in inflammatory bowel disease

INTERVENTION: Intervention 1: Intervention group: Silymarin tablets (Gol Daro Company) with a dose of 5 mg/kg in divided doses three times a day for three months on a daily basis. Intervention 2: Control group: Three times a day placebo for three months on a daily basis. CONDITION: Inflammatory Bowel Disease. ; Noninfective inflammatory bowel disease K50‐K52 PRIMARY OUTCOME: Clinical Symptoms. Timepoint: Before the start of the study, one month and three months after the start of the intervention. Method of measurement: Questionnaire including abdominal pain, frequency of defecation, mobility and endoscopy findings. INCLUSION CRITERIA: Inflammatory bowel disease